Proteinase-activated receptor-2 in the skin: Receptor expression, activation and function during health and disease

Drug News and Perspectives

Volumn 21, Issue 7, 2008, Pages 369-381

  Rattenholl, Anke ^a   Steinhoff, Martin ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 2; CALCITONIN GENE RELATED PEPTIDE; CALPAIN 1; CALPAIN 2; CATHEPSIN G; CYCLOOXYGENASE 2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; LEUKOCYTE ELASTASE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MATRIPTASE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOBLASTIN; PLASMIN; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 2 BLOCKING AGENT; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; RECEPTOR BLOCKING AGENT; SERINE PROTEINASE INHIBITOR; SUBSTANCE P; TRANSFORMING GROWTH FACTOR BETA; TRYPSIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADAPTIVE IMMUNITY; ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CYTOKINE RELEASE; DENDRITIC CELL; ENDOTHELIUM CELL; EOSINOPHIL; GENE MUTATION; HOMEOSTASIS; HUMAN; INNATE IMMUNITY; KERATINOCYTE; MACROPHAGE; MAST CELL; MELANOMA; MONOCYTE; NETHERTON DISEASE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PERIODONTITIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PRURITUS; PSORIASIS; RHINOSINUSITIS; SENSORY NERVE; SKIN CARCINOMA; SKIN DISEASE; SKIN FIBROBLAST; SKIN FUNCTION; SKIN INFLAMMATION; SKIN MALFORMATION; SKIN PAIN; SKIN PERMEABILITY; SKIN PIGMENTATION; T LYMPHOCYTE;

ANIMALS; CYTOKINES; GENE EXPRESSION; HUMANS; IMMUNITY, ACTIVE; IMMUNITY, INNATE; INFLAMMATION; MOUTH MUCOSA; RECEPTOR, PAR-2; SKIN; SKIN DISEASES; SKIN NEOPLASMS;

EID: 58849157836     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2008.21.7.1255294     Document Type: Article

References (143)

1. Shpacovitch, V., Feld, M., Bunnett, N.W. et al. Protease-activated receptors: novel PARtners in innate immunity. Trends Immunol 2007, 28(12): 541-50.
2. Shpacovitch, V., Feld, M., Hollenberg, M.D. et al. Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity. J Leukoc Biel 2008, 83(6): 1309-22.
3. McGrath, J.A., Eady, R.A.J. and Pope, F.M. Anatomy and organization of human skin. In: Rook's Textbook of Dermatology (7th Edition), Vol. 1. D. Burns, A., Kinghom, B.P., Griffiths, C.E., Cox N., Breathnach S.M. (Eds.). Blackwell Publishing: Oxford 2004.
4. Wakita, H., Furukawa, F. and Takigawa, M. Thrombin and trypsin induce granulocyte-macrophage colony-stimulating factor and interleukin-6 gene expression in cultured normal human keratinocytes. Proc Assoc Am Physicians 1997, 109(2): 190-207.
5. Derian, CX., Eckardt, A.J. and Andrade-Gordon, P. Differential regulation of human keratinocyte growth and differentiation by a novel family of protease-activated receptors. Cell Growth Differ 1997, 8(7): 743-9.
6. Seiberg, M., Paine, C., Sharlow, E. et al. The protease-activated receptor 2 regulates pigmentation via keratinocyte-melanocyte interactions. Exp Cell Res 2000, 254(1): 25-32.
7. Buddenkotte, J., Stroh, C., Engels, I.H. et al. Agonists of proteinase-activated receptor-2 stimulate upregulation of intercellular cell adhesion molecule-1 in primary human keratinocytes via activation of NF-kappa B. J Invest Dermatol 2005, 124(1): 38-45.
8. Hou, L, Kapas, S, Cruchley A.T. et al. Immunolocalization of protease-activated receptor-2 in skin: receptor activation stimulates interleukin-8 secretion by keratinocytes in vitro. Immunology 1998, 94(3): 356-62.
9. Iwakiri, K., Ghazizadeh, M,. Jin, E. et al. Human airway tryosin-like protease induces PAR-2-mediated IL-8 release in psoriasis vulgaris. J Invest Dermatol 2004, 122(4): 937-44.
10. Rattenholl, A., Seeliger, S., Buddenkotte, J. et al. Proteinase-activated receptor-2 (PAR2): a tumor suppressor in skin carcinogenesis. J Invest Dermatol 2007, 127(9): 2245-52.
11. Lourbakos A., Potempa J., Travis J. et al. Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect Immun 2001, 69(8): 5121-30.
12. Dommisch H., Chung W.O., Rohani M.G. et al. Protease-activated receptor 2 mediates human beta-defensin 2 and CC chemokine ligand 20 mRNA expression in response to proteases secreted by Porphyromonas gingivalis. Infect Immun 2007, 75(9): 4326-33.
13. Rudack, C., Steinhoff, M., Mooren, F. et al. PAR2 activation regulates IL-8 and GRO-alpha synthesis by NF-kappaB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epithelium. Clin Exp Allergy 2007, 37(7): 1009-22.
14. Kauffman, H.F., Tamm, M., Timmerman, J.A. et al. House dust mite major allergens Der p 1 and Der p 5 activate human airway-derived epithelial cells by protease-dependent and protease-independent mechanisms. Clin Mot Allergy 2006, 4: 5.
15. Adam, E., Hansen, K.K., Astudillo Fernandez, O. et al. The house dust mite allergen Der p 1, unlike Der p 3, stimulates the expression of interleukin-8 in human airway epithelial cells via a proteinase-activated receptor-2-independent mechanism. J Biol Chem 2006, 281(11): 6910-23.
16. Page, K., Hughes, V.S., Odoms, K.K. et al. German cockroach proteases regulate interleukin-8 expression via nuclear factor for interleukin-6 in human bronchial epithelial cells. Am J Respir Cell Mol Biol 2005, 32(3): 225-31.
17. Kida, Y., Inoue, H., Shimizu, T. et al. Serratia marcescens serralysin induces inflammatory responses through protease-activated receptor 2. Infect Immun 2007, 75(1): 164-74.
18. Hachem, J.P., Houben, E., Crumrine, D. et al. Serine protease signaling of epidermal permeability barrier homeostasis. J Invest Dermatol 2006, 126(9): 2074-86.
19. Demerjian, M., Hachem, J.P., Tschachler, E. et al. Acute modulations in permeability barrier function regulate epidermal cornification: role of caspase-14 and the protease-activated receptor type 2. Am J Pathol 2008, 172(1): 86-97.
20. Frungieri, M.B., Weidinger, S., Meineke, V. et al. Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, Prostaglandins, and PPARgamma: Possible relevance to human fibrotic disorders. Proc Natl Acad Sci U S A 2002, 99(23): 15072-7.
21. Gruber, B.L., Kew, R.R., Jelaska, A. et al. Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J Immunol 1997, 158(5): 2310-7.
22. Borensztajn, K., Stiekema, J., Nijmeijer, S. et at. Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation. Am J Pathol 2008, 172(2): 309-20.
23. Uehara, A., Muramoto, K., Imamura, T. et al. Arginine-specific gingipains from Porphyromonas gingivalis stimulate production of hepatocyte growth factor (scatter factor) through protease-activated receptors in human gingival fibroblasts in culture. J Immunol 2005, 175(9): 6076-84.
24. Uehara, A., Muramoto, K., Takada, H. et al. Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2. J Immunol 2003, 170(11): 5690-6.
25. Shpacovitch, V.M., Brzoska, T., Buddenkotte, J. et al. Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells. J Invest Dermatol 2002, 118(2): 380-5.
26. Houliston, R.A., Keogh, R.J., Sugden, D. et al. Protease-activated receptors upregulate cyclooxygenase-2 expression in human endothelial cells. Thromb Haemost 2002, 88(2): 321-8.
27. Syeda, F., Grosjean, J., Houliston, R.A. et al. Cyclooxygenase-2 induction and prostacyclin release by protease-activated receptors in endothelial cells require cooperation between mitogen-activated protein kinase and NF-kappaB pathways. J Biol Chem 2006, 281(17): 11792-804.
28. Cleator, J.H., Zhu, W.Q., Vaughan, D.E. et al. Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP. Blood 2006, 107(7): 2736-44.
29. Tennant, G.M., Wadsworth, R.M. and Kennedy, S. PAR2 mediates increased inflammatory cell adhesion and neointima formation following vascular injury in the mouse. Atherosclerosis 2008, 198(1): 57-64.
30. Steinhoff, M., Vergnolle, N., Young, S.H. et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 2000, 6(2): 151-8.
31. Moormann, C., Artuc, M., Pohl, E. et al. Functional characterization and expression analysis of the proteinase-activated receptor-2 in human cutaneous mast cells. J Invest Dermatol 2006, 126(4): 746-55.
32. He, S.H., Xie, H., Fu, Y.L. Activation of human tonsil and skin mast cells by agonists of proteinase activated receptor-2. Acta Pharmacol Sin 2005, 26(5): 568-74.
33. Shpacovitch, V.M., Varga, G., Strey, A. et al. Agonists of proteinase-activated receptor-2 modulate human neutrophil cytokine secretion, expression of cell adhesion molecules, and migration within 3-D collagen lattices. J Leukoc Biol 2004, 76(2): 388-98.
34. Shpacovitch, V.M., Seeliger, S., Huber-Lang, M. et al. Agonists of proteinase-activated receptor-2 affect transendothelial migration and apoptosis of human neutrophils. Exp Dermatol 2007, 16(10): 799-806.
35. Miike, S., McWilliam, A.S., Kita, H. Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2. J Immunol 2001, 167(11): 6615-22.
36. Bolton, S.J., McNulty, C.A., Thomas, R.J. et al. Expression of and functional responses to protease-activated receptors on human eosinophils. J Leukoc Biol 2003, 74(1): 60-8.
37. Temkin, V, Kantor, B., Weg, V. et al. Tryptase activates the mitogen-activated protein kinase/activator protein-1 pathway in human peripheral blood eosinophils, causing cytokine production and release. J Immunol 2002, 169(5): 2662-9.
38. Wang, H. and Huang, Y. Proteinase activated receptor-2 mediated IL-5, IL-6 and RANTES release from human eosinophils. Cell Biol Int, in press.
39. Johansson, U., Lawson, C., Dabare, M. et al. Human peripheral blood monocytes express protease receptor-2 and respond to receptor activation by production of IL-6, IL-8, and IL-1 {beta}. J Leukoc Biol 2005, 78(4): 967-75.
40. Uehara, A., Iwashiro, A., Sato, T. et al. Antibodies to proteinase 3 prime human monocytic cells via protease-activated receptor-2 and NF-kappaB for Toll-like receptor- and NOD-dependent activation. Mol Immunol 2007, 44(14): 3552-62.
41. Csernok, E., Ai, M., Gross, W.L. et al. Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway. Blood 2006, 107(11): 4440 8.
42. Uehara, A., Imamura, T., Potempa, J. et al. Gingipains from Porphyromonas gingivalis synergistically induce the production of proinflammatory cytokines through protease-activated receptors with Toll-like receptor and NOD1/2 ligands in human monocytic cells. Cell Microbiol 2008, 10(5): 1181-9.
43. Bar-Shavit, R., Maoz, M., Yongjun, Y. et al. Signalling pathways induced by protease-activated receptors and integrins in T cells. Immunology 2002, 105(1): 35-46.
44. Li, T. and He S. Induction of IL-6 release from human T cells by PAR1 and PAR2 agonists. Immunol Cell Biol 2006, 84(5): 461-6.
45. Ebeling, C., Lam, T., Gordon, J.R. et al. Proteinase-activated receptor-2 promotes allergic sensitization to an inhaled antigen through a TNF-mediated pathway. J Immunol 2007, 179(5): 2910-7.
46. Devlin, M.G., Gasser, R.B. and Cocks, T.M. Initial support for the hypothesis that PAR2 is involved in the immune response to Nippostrongylus brasiliensis in mice. Parasitol Res 2007, 101(1): 105-9.
47. Hollenberg, M.D. and Compton, S.J. International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol Rev 2002, 54(2): 203-17.
48. Coughlin, S.R. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 2005, 3(8): 1800-14.
49. Ramachandran, R., Hollenberg, M.D. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol 2008, 153(Suppl 1): S263-82.
50. Homey B. Chemokines and inflammatory skin diseases. Adv Dermatol 2005, 21: 251-77.
51. Homey, B., Steinhoff, M., Ruzicka, T. et al. Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 2006, 118(1): 178-89.
52. Oberst, M., Anders, J., Xie, B. et al. Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. Am J Pathol 2001, 158(4): 1301-11.
53. Oberst, M.D., Singh, B., Ozdemirli. M. et al. Characterization of matriptase expression in normal human tissues. J Histochem Cytochem 2003, 51(8): 1017-25.
54. Lin, C.Y., Anders, J., Johnson, M. et al. Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J Biol Chem 1999, 274(26): 18237-42.
55. Takeuchi, T., Harris, J.L., Huang, W. et al. Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem 2000, 275(34): 26333-42.
56. Oberst, M.D., Williams, C.A., Dickson, R.B. et al. The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. J Biol Chem 2003, 278(29): 26773-9.
57. List, K., Szabo, R., Molinolo, A. et al. Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation. Genes Dev 2005 19(16): 1934-50.
58. List, K., Haudenschild, C.C., Szabo, R. et al. Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene 2002, 21(23): 3765-79.
59. List, K., Szabo, R., Wertz, P.W. et al. Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/ MT-SP1. J Cell Biol 2003, 163(4): 901-10.
60. Basel-Vanagaite, L., Attia, R., Ishida-Yamamoto, A. et al. Autosomal recessive ichthyosis with hypotrichosis caused by a mutation in ST14, encoding type II transmembrane serin eprotease matriptase. Am J Hum Genet 2007, 90(3): 467-77.
61. Cheng, M.F., Jin, J.S., Wu, H.W. et al. Matriptase expression in the normal and neoplastic mast cells. Eur J Dermatol 2007, 17(5): 375-80.
62. Kilpatrick, L.M., Harris, R.L., Owen, K.A. et al. Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase. Blood 2006, 108(8): 2616-23.
63. Stefansson, K., Brattsand, M., Roosterman, D. et al. Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases. J Invest Dermatol 2008, 128(1): 18-25.
64. Brattsand, M. and Egelrud, T. Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J Biol Chem 1999, 274(42): 30033-40.
65. Komatsu, N., Saijoh, K., Sidiropoulos, M. et al. Quantification of human tissue kallikreins in the stratum corneum: dependence on age and gender. J Invest Dermatol 2005, 125(6): 1182-9.
66. Stefansson, K., Brattsand, M., Ny, A. et al. Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum. Biol Chem 2006, 387(6): 761-8.
67. Komatsu N., Saijoh K., Kuk C. et al. Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy. Br J Dermatol 2007, 156(5): 875-83.
68. Komatsu, N., Saijoh, K., Kuk, C. et al. Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients. Exp Dermatol 2007, 16(6): 513-9.
69. Törmä, H., Lindberg, M. and Berne, B. Skin barrier disruption by sodium lauryl sulfate-exposure alters the expressions of involucrin, transglutaminase 1, profilaggrin, and kallikreins during the repair phase in human skin in vivo. J Invest Dermatol 2008, 128(5): 1212-9.
70. Caubet, C., Jonca, N., Brattsand, M. et al. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 2004, 122(5): 1235-44.
71. Deraison, C., Bonnart, C., Lopez, F. et al. LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Mol Biol Cell 2007, 18(9): 3607-19.
72. Borgoño, C.A., Michael, I.P., Komatsu, N. et al. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J Biol Chem 2007, 282(6): 3640-52.
73. Komatsu, N., Saijoh, K., Jayakumar, A. et al. Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients. J Invest Dermatol 2008, 128(5): 1148-59.
74. Compton, S.J., Renaux, B. Wijesuriya, S.J. et al. Glycosylation and the activation of proteinase-activated receptor 2 (PAR(2)) by human most cell tryptase. Br J Pharmacol 2001, 134(4): 705-18.
75. Compton, S.J., McGuire, J.J., Saifeddine, M. et al. Restricted ability of human mast cell tryptase to activate proteinase-activated receptor-2 in rat aorta. Can J Physiol Pharmacol 2002, 80(10): 987-92.
76. Bank, U. and Ansorge, S. More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control. J Leukoc Biol 2001, 69(2): 197-206.
77. Loew, D., Perrault, C., Morales, M. et al. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry. Biochemistry 2000, 39(35): 10812-22.
78. Dulon, S., Candé, C., Bunnett, N.W. et al. Proteinase-activated receptor-2 and human lung epithelial cells: disarming by neutrophil serine proteinases. Am J Respir Cell Mol Biol 2003, 28(3): 339-46.
79. Dulon, S., Leduc, D., Cottrell, G.S. et al. Pseudomonas aeruginosa elastase disables proteinase-activated receptor 2 in respiratory epithelial cells. Am J Respir Cell Mol Biol 2005, 32(5): 411-9.
80. Speert, D.P. Molecular epidemiology of Pseudomonas aeruginosa. Front Biosci 2002, 7:e354-61.
81. Versteeg, H.H., Schaffner, F., Kerver, M. et al. Inhibition of tissue factor signaling suppresses tumor growth. Blood 2008, 111(1): 190-9.
82. Matsushita, Y., Shimada, Y., Kawara, S. et al. Autoantibodies directed against the protease inhibitor calpastatin in psoriasis. Clin Exp Immumol 2005, 139(2): 355-62.
83. Ubl, J.J., Grishina, Z.V., Sukhomlin, T.K. et al. Human bronchial epithelial cells express PAR-2 with different sensitivity to thermolysin. Am J Physiol Lung Cell Mol Physiol 2002, 282(6): L1339-48.
84. Li, J., Eriksson, P.O., Hansson, A. et al. Plasmin/plasminogen is essential for the healing of tympanic membrane perforations. Thromb Haemost 2006, 96(4): 512-9.
85. Scott, G., Deng, A., Rodriguez-Burford, C. et al. Protease-activated receptor 2, a receptor involved in melanosome transfer is upregulated in human skin by ultraviolet irradiation. J Invest Dermatol 2001, 117(6): 1412-20.
86. D'Andrea, M.R., Derian, C.K., Leturcq, D. et al. Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J Histochern Cytochem 1998, 46(2): 157-64.
87. Steinhoff, M., Corvera, C.U., Thoma, M.S. et al. Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase. Exp Dermatol 1999, 8(4): 282-94.
88. Santulli, R.J., Derian, C.K., Darrow, A.L. et al. Evidence for the presence of a protease-activated receptor distinct from the thrombin receptor in human keratinocytes. Proc Natl Acad Sci U S A 1995, 92(20): 9151-5.
89. Schechter, N.M., Brass, L.F., Lavker, R.M. et al. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts. J Cell Physiol 1998, 176(2): 365-73.
90. Sharlow, E.R., Paine, C.S., Babiarz, L. et al. The protease-activated receptor-2 upregulates keratinocyte phagocytosis. J Cell Sci 2000, 113 (Pt. 17): 3093-101.
91. Heufler, C., Koch, F. and Schuler, G. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 1988, 167(2): 700-5.
92. Kaplan, G., Walsh, G., Guido, L.S. et al. Novel responses of human skin to intradermal recombinant granulocyte/ macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J Exp Med 1992, 175(6): 1717-28.
93. Braunstein, S., Kaplan, G., Gottlieb, A.B. et al. GM-CSF activates regenerative epidermal growth and stimulates keratinocyte Proliferation in human skin in vivo. J Invest Dermatol 1994, 103(4): 601-4.
94. Davies, M., Paterson, I.C., Ganapathy, A. et al. Cell death induced by N-(4-hydroxyphenyl)retinamide in human epidermal keratinocytes is modulated by TGF-beta and diminishes during the progression of squamous cell carcinoma. Int J Cancer 2006, 119(12): 2803-11.
95. Hachem, J.P., Crumrine, D., Fluhr, J. et al. pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 2003, 121(2): 345-53.
96. Brattsand, M., Stefansson, K., Lundh, C. et al. A proteolytic cascade of kallikreins in the stratum corneum. J Invest Dermatol 2005, 124(1): 198-203.
97. Jeong, S.K., Kim, H.J., Youm, J.K. et al. Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery. J Invest Dermatol 2008, 128(8): 1930-9.
98. Reed, C.E. and Kita H. The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immumol 2004, 114(5): 997-1008.
99. Sokolova, E. and Reiser G. A novel therapeutic target in various lung diseases: airway proteases and protease-activated receptors. Pharmacol Ther 2007, 115(1): 70-83.
100. Seiberg, M., Paine, C., Sharlow, E. et al. Inhibition of melanosome transfer results in skin lightening. J Invest Dermatol 2000, 115(2): 162-7.
101. Paine, C., Sharlow, E., Liebel, F. et al. An alternative approach to depigmentation by soybean extracts via inhibition of the PAR2 pathway. J Invest Dermatol 2001, 116(4): 587-95.
102. Massi D., Naldini A., Ardinghi C. et al. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma. Hum Pathol 2005, 36(6): 676-85.
103. Shi, X., Gangadharan, B., Brass, L.F. et al. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. Mol Cancer Res 2004, 2(7): 395-402.
104. Hoover, D.M., Boulegue, C., Yang, D. et al. The structure of human macrophage inflammatory protein-3alpha/CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins. J Biol Chem 2002, 277(40): 37647-54.
105. Al-Aoukaty, A., Rolstad, B., Giaid, A. et al. MIP-3alpha, MIP-3beta and fractalkine induce the locomotion and the mobilization of intracellular calcium, and activate the heterotrimeric G proteins in human natural killer cells. Immunology 1998, 95(4): 618-24.
106. Liao, F., Shirakawa, A.K., Foley, J.F. et al. Human B cells become highly responsive to macrophage-inflammatory protein-3 alpha/CC chemokine ligand-20 after cellular activation without changes in CCR6 expression or ligand binding. J Immunol 2002, 168(10): 4871-80.
107. Dieu, M.C., Vanbervliet, B., Vicari, A. et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 1998, 188(2): 373-86.
108. Uehara, A., Sugawara, S., Muramoto, K. et al. Activation of human oral epithelial cells by neutrophil proteinase 3 through protease-activated receptor-2. J Immunol 2002, 169(8): 4594-603.
109. Rawlings, N.D., Morton, F.R., Kok, C.Y. et al. MEROPS: the peptidase database. Nucleic Acids Res 2008, 36(Database issue): D320-5.
110. Braun, M.G., Csernok, E., Gross, W.L. et al. Proteinase 3, the target antigen of anticytoplasmic antibodies circulating in Wegener's granulomatosis. Immunolocalization in normal and pathologic tissues. Am J Pathol 1991, 139(4): 831-8.
111. Lüdemann, J., Utecht, B., Gross, W.L. Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 1990, 171(1): 357-62.
112. Uehara, A., Sugawara, Y., Sasano, T. et al. Proinflammatory cytokines induce proteinase 3 as membrane-bound and secretory forms in human oral epithelial cells and antibodies to proteinase 3 activate the cells through protease-activated receptor-2. J Immunol 2004, 173(6): 4179-89.
113. Novo, E. and Viera, N. Antineutrophil cytoplasmic antibodies: A missing link in the pathogenesis of periodontal disease? J Periodontal Res 1996, 31(5): 365-8.
114. Novo, E., García-Mac Gregor, E., Nava, S. et al. A possible defective estimation of antineutrophil cytoplasmic antibodies in systemic lupus erythematosus due to the coexistence of periodontitis: preliminary observations. P R Health Sci J 1997, 16(4): 369-73.
115. Gruber, B.L., Marchese, M.J., Santiago-Schwarz, F. et al. Protease-activated receptor-2 (PAR2) expression in human fibroblasts is regulated by growth factors and extracellular matrix. J Invest Dermatol 2004, 123(5): 832-9.
116. Materazzi, S., Pellerito, S., Di Serio, C. et al. Analysis of protease-activated receptor-1 and -2 in human scar formation. J Pathol 2007, 212(4): 440-9.
117. Reisinger, K., Kaufmann, R. and Gille, J. Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/ SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription. J Cell Sci 2003 116(Pt. 2): 225-38.
118. Dunsmore, S.E., Rubin, J.S., Kovacs, S.O. et al. Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production. J Biol Chem 1996, 271(40): 24576-82.
119. Bennett, J.H., Morgan, M.J., Whawell, S.A. et al. Metalloproteinase expression in normal and malignant oral keratinocytes: stimulation of MMP-2 and -9 by scatter factor. Eur J Oral Sci 2000, 108(4): 281-91.
120. Hollande, F., Blanc, E.M., Bali, J.P. et al. HGF regulates light junctions in new non-tumorigenic gastric epithelial cell line. Am J Physiol Gastrointest Liver Physiol 2001, 280(5): G910-21.
121. Blair, R.J., Meng, H., Marchese, M.J. et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest 1997, 99(11): 2691-700.
122. Nystedt, S., Ramakrishnan, V. and Sundelin, J. The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J Biol Chem 1996, 271(25): 14910-5.
123. Ritchie, E., Saka, M., Mackenzie, C. et al. Cytokine upregulation of proteinase-activated-receptors 2 and 4 expression mediated by p38 MAP kinase and inhibitory kappa B kinase beta in human endothelial cells. Br J Pharmacol 2007, 150(8): 1044-54.
124. Wheeler-Jones, C.P. Regulation of endothelial prostacyclin synthesis by Protease-activated receptors: mechanisms and significance. Pharmacol Rep 2008, 60(1): 109-18.
125. Paszcuk, A.F., Quintão, N.L., Fernandes, E.S. et al. Mechanisms underlying the nociceptive and inflammatory responses induced by trypsin in the mouse paw. Eur J Pharmacol 2008, 581(1-2): 204-15.
126. Costa, R., Marotta, D.M., Manjavachi, M.N. et al. Evidence for the role of neurogenic inflammation components in trypsin-elicited scratching behaviour in mice. Br J Pharmacol 2008, 154(5): 1094-103.
127. Benoist C. and Mathis D. Mast cells in autoimmune disease. Nature 2002, 420(6917): 875-8.
128. He, S.H., He, Y.S. and Xie, H. Activation of human colon mast cells through proteinase activated receptor-2. World J Gastroenterol 2004, 10(3): 327-31.
129. Ozawa, M., Terui, T., Tagami, H. Localization of IL-8 and complement components in lesional skin of psoriasis vulgaris and pustulosis palmaris et plantaris. Dermatology 2005, 211(3): 249-55.
130. Grutkoski, P.S., D'Amico, R., Ayala, A. et al. IL- 1 beta stimulation induces paracrine regulation of PMN function and apoptosis. Shock 1999 12(5): 373-81.
131. Biffl, W.L., Moore, E.E., Moore, F.A. et al. Interleukin-6 suppression of neutrophil apoptosis is neutrophil concentration dependent. J Leukoc Biol 1995, 58(5): 582-4.
132. Horn, F., Henze, C. and Heidrich, K. Interleukin-6 signal transduction and lymphocyte function. Immunobiology 2000, 202(2): 151-67.
133. Wüthrich, B., Cozzio, A., Roll, A. et al. Atopic eczema: genetics or environment? Ann Agric Environ Med 2007, 14(2): 195-201.
134. Kasperkiewicz, M. and Zillikensm, D. The pathophysiology of bullous pemphigoid. Clin Rev Allergy Immumol 2007, 33(1-2): 67-77.
135. Falcone, F.H., Morroll, S. and Gibbs, B.F. Lack of protease activated receptor (PAR) expression in purified human basophils. Inflamm Res 2005, 54(Suppl 1): S13-4.
136. Yousefi, S., Hemmann, S., Weber, M. et al. IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. J Immunol 1995, 154(10): 5481-90.
137. Itakura, A., Kikuchi, Y., Kouro, T. et al. Interleukin 5 plays an essential role in elicitation of contact sensitivity through dual effects on eosinophils and B-1 cells. Int Arch Allergy Immunol 2006, 140(Suppl 1): 8-16.
138. de Nadaï, P., Chenivesse, C., Gilet, J. et al. CCR5 usage by CCL5 induces a selective leukocyte recruitment in human skin xenografts in vivo. J Invest Dermatol 2006, 126(9): 2057-64.
139. Serbina, N.V., Jia, T., Hol1, T.M. et al. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 2008, 26:421-52.
140. McInnes, I.B. Cytokine targeting in psoriasis and psoriatic arthritis: beyond TNFalpha. Ernst Schering Res Found Workshop 2006, (56): 29-44.
141. Fields, R.C., Schoenecker, J.G., Hart, J.P. et al. Protease-activated receptor-2 signaling triggers dendritic, cell development. Am J Pathol 2003, 162(6): 1817-22.
142. Shichijo, M, Kondo, S, Ishimori, M. et al. PAR2 deficient CD4+ T cells exhibit down-regulation of IL-4 and upregulation of IFN-gamma after antigen challenge in mice. Allergol Int 2006, 55(3): 271-8.
143. Palmer, C.N., Irvine, A.D., Terron-Kwiat-kowski, A. et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006, 38(4): 441-6.